Jove
Visualize
联系我们

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Principles of Drug Action01:24

Principles of Drug Action

5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

206
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
206
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

179
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
179

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Interplay between Gut Microbiota and Diet-Induced Kidney Protection.

Kidney360·2026
Same author

Cardiolipin preserves T<sub>reg</sub> metabolic fitness and immune homeostasis in the gut.

Nature metabolism·2026
Same author

Phenotypic and metabonomics studies of FMOs in C. elegans and their roles in lifespan extension.

Metabolomics : Official journal of the Metabolomic Society·2025
Same author

Chemotherapy modulation by a cancer-associated microbiota metabolite.

Cell systems·2025
Same author

Enhancing autophagy by redox regulation extends lifespan in Drosophila.

Nature communications·2025
Same author

Carbamazepine-exposed earthworms are characterized by tissue-specific accumulation patterns and transcriptional profiles.

Environment international·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 14, 2025

High Throughput Co-culture Assays for the Investigation of Microbial Interactions
07:00

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

Published on: October 15, 2019

9.8K

微生物将药物放入 (作用) 中.

Jennifer van der Laan1, Filipe Cabreiro2

  • 1CECAD, University of Cologne, Joseph-Stelzmann-Str. 26, Cologne 50931, North Rhine-Westphalia, Germany.

Trends in endocrinology and metabolism: TEM
|September 5, 2024
PubMed
概括

肠道微生物群影响药物的有效性和宿主健康. 利用这些微生物为推进精准医学和改善治疗结果提供了一个有前途的战略.

关键词:
我们的肠道微生物组.主体生理学 主体生理学药理学 药理学 药理学 药理学 药理学

更多相关视频

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.0K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K

相关实验视频

Last Updated: Jun 14, 2025

High Throughput Co-culture Assays for the Investigation of Microbial Interactions
07:00

High Throughput Co-culture Assays for the Investigation of Microbial Interactions

Published on: October 15, 2019

9.8K
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.0K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K

科学领域:

  • 微生物学 微生物学
  • 药理学 药理学是指药理学的学科.
  • 主体生理学 主体生理学

背景情况:

  • 肠道微生物组在宿主恒温中发挥着至关重要的作用.
  • 肠道微生物显著影响宿主向药物的新陈代谢和疗效.
  • 肠道微生物群,营养素,药物和宿主生理之间存在复杂的相互作用.

研究的目的:

  • 探索肠道微生物组与药物疗效之间的复杂关系.
  • 确定利用肠道微生物群的战略,以提高治疗结果.
  • 通过针对微生物的干预措施,推进精准医学领域.

主要方法:

  • 对肠道微生物组与药物相互作用的现有文献的审查.
  • 对宿主-微生物-药物代谢途径的分析.
  • 探索计算和实验方法来调节肠道微生物群.

主要成果:

  • 肠道微生物可以显著改变各种药物的生物可用性和活性.
  • 微生物组的组成可以预测个体对药物治疗的反应.
  • 针对肠道微生物组为个性化药物治疗方案提供了机会.

结论:

  • 肠道微生物组是决定药物疗效和患者反应的关键因素.
  • 利用肠道微生物群具有改善药物治疗和推进精准医学的巨大潜力.
  • 对微生物组与药物相互作用的进一步研究对于临床转化至关重要.